Total raised
$650K
Last: Undisclosed 2019-08
Stage
Seed
Founded
2018
Headcount
6
HQ
Ra'anana
Sector
Health Tech & Life Sciences
About
Veoli is developing an inhaler that enables patients to use cannabis oil at an accurate dosage without the need for heat, evaporation, or burning. The company's main technology is based on a device that turns liquid into micron-sized droplets that can be inhaled and absorbed into the lungs. As no heat is involved in the process, there is no change in the properties of the cannabis and no associated byproducts are produced. Connection to a smartphone enables remote quantity control by a medical team. Veoli was established in Sanara Ventures' technological incubator.
Funding history · 2 rounds · $650K total
2019-08
Undisclosed
$400K
2019-03
Undisclosed
$250K
Company Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- What is Veoli's primary product?
- Veoli is developing an inhaler designed for patients to use cannabis oil at an accurate dosage without heat, evaporation, or burning. The device converts liquid into micron-sized droplets for lung absorption.
- When was Veoli established and where?
- Veoli was founded in December 2018 and was established within Sanara Ventures' technological incubator in Ra'anana, Israel.
- What is the current operational status of Veoli?
- According to startupim data, Veoli is currently inactive and ceased operations in August 2021.
- What was Veoli's total funding raised?
- Veoli raised a total of $650,000 in funding. For a full financing history, please refer to startupim.
- Which investor participated in Veoli's March 2019 funding round?
- In March 2019, Sanara Ventures invested in an undisclosed round for Veoli.
- Which investor participated in Veoli's August 2019 funding round?
- In August 2019, Merchavia Holdings invested in an undisclosed round for Veoli.
- How many employees did Veoli have?
- Veoli had between 1 and 10 employees, with an exact count of 6.
- What technology does Veoli's inhaler incorporate for patient use?
- Veoli's inhaler connects to a smartphone, enabling remote quantity control by a medical team.
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyMedical CannabisDrug DeliveryMedical DevicesMedical Treatment & Therapeutics
Technologies
CommunicationsBluetoothSensing
Target customers
Healthcare & Life SciencesHealthcarePatientsProviders
Business model
B2BB2C
Tags
medical-cannabisdrug-deliveryhome-carepulmonarymedical-technologiesinhalationmobile-applicationsmedical-devicescannabis